News on Roche’s Competitive Ventures in the Weight Loss Drug Market
Tuesday, 17 September 2024, 12:01
News on Roche's Competitive Ventures in the Weight Loss Drug Market
Roche's new weight loss injection and pill are creating waves in the medical field. At the recent EASD conference, early-stage data indicated promising results, highlighting its potential effectiveness. This comes as Oura makes strides in the metabolic health sector through its acquisition of Veri, further intensifying competition.
Key Highlights
- Roche presents early data.
- Oura acquires Veri.
- Focus on obesity treatment advancements.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.